ANDREW DEIN: Open Payments
NPI 1912007303 · HIGH POINT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 12 payments from 7 companies in 2025. Trend: 2023 $14 · 2024 $107 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $86 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $51 |
| Eisai Inc. | 2 | $41 |
| Biogen, Inc. | 1 | $23 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $19 |
| ARGENX US, INC. | 1 | $18 |
| Merz Pharmaceuticals, LLC | 1 | $14 |
Products named: QULIPTA, JOURNAVX, Leqembi, BOTOX, TYSABRI, LUMRYZ, VYVGART HYTRULO, Xeomin.
Industry payments across NC — which companies pay providers there.
